PCRX
Pacira BioSciences, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$24.69
+0.86%Forward multiples
Based on analyst estimates
- P/E forward
- 8.05x
- P/E 2026E
- 8.48x
- P/E 2027E
- 7.13x
- P/E 2028E
- 5.40x
- P/S forward
- 1.30x
Trailing multiples
Trailing twelve months
- P/E TTM
- 70.12x
- PEG TTM
- 0.09x
- Price / book
- 1.46x
- Price / sales
- 1.32x
- Price / cash flow
- 5.24x
Enterprise value
- Enterprise value
- $1.1B
- EV / sales
- 1.53x
- EV / EBITDA
- 9.98x
- EV / EBIT
- 62.09x
- Market cap
- $984.2M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026